Related Experiment Videos
Isolation of trimethoprim-resistant, sulfonamide-susceptible Enterobacteriaceae from urinary tract infections
Antimicrobial Agents and Chemotherapy
|April 1, 1983
Abstract:
The isolation of trimethoprim-resistant, sulfonamide-susceptible Enterobacteriaceae causing urinary tract infections is reported. The appearance of these strains followed the introduction of trimethoprim alone for use as treatment. Trimethoprim resistance was attributable to plasmids or transposons less frequently in sulfonamide-susceptible Escherichia coli isolates than in sulfonamide-resistant strains.
Insights
Trimethoprim-resistant, sulfonamide-susceptible Enterobacteriaceae emerged in urinary tract infections after trimethoprim monotherapy. Resistance mechanisms were less frequent in susceptible E. coli compared to resistant strains.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Urinary tract infections (UTIs) are common bacterial infections.
- Antimicrobial resistance is a growing global health concern.
- Trimethoprim is a widely used antibiotic for UTIs.
Purpose of the Study:
- To report the emergence of trimethoprim-resistant, sulfonamide-susceptible Enterobacteriaceae causing UTIs.
- To investigate the association between trimethoprim monotherapy and the appearance of these resistant strains.
- To compare the genetic basis of trimethoprim resistance in susceptible versus resistant strains.
Main Methods:
- Bacteriological isolation and identification of Enterobacteriaceae from UTI patients.
- Antimicrobial susceptibility testing for trimethoprim and sulfonamides.
- Plasmid and transposon analysis to determine resistance mechanisms.
Main Results:
- Isolation of trimethoprim-resistant, sulfonamide-susceptible Enterobacteriaceae.
- Correlation between the introduction of trimethoprim alone and the prevalence of these strains.
- Lower frequency of plasmid or transposon-mediated resistance in sulfonamide-susceptible E. coli compared to sulfonamide-resistant strains.
Conclusions:
- Trimethoprim monotherapy can select for resistant Enterobacteriaceae.
- The genetic determinants of trimethoprim resistance may differ based on sulfonamide susceptibility.
- Monitoring antimicrobial resistance patterns is crucial for effective UTI treatment.